BIRMINGHAM, Ala.--(BUSINESS WIRE)--Atherotech, Inc., a pioneer in cardiodiagnostic cholesterol testing technology, announced today that it is adding a highly accurate determination of apolipoprotein B (apo B) to its VAP® (Vertical Auto Profile) Expanded Cholesterol Test at no additional cost. Currently, the VAP Test directly measures total cholesterol, low-density and high-density lipoproteins (LDL, and HDL with its important subclasses) while satisfying the recommendations of the NCEP ATP III panel by reporting emerging risk factors, residual risk parameters and secondary targets of therapy including non-HDL cholesterol levels.
